Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/AstraZeneca prices €2.55bn euro bond across four tranches for general corporate use

AZN

$165.59

-$4.07 -2.40%

AstraZeneca prices €2.55bn euro bond across four tranches for general corporate use

Company Fundamentals

25 Aug 2026

Proactive Investors

View Source

Neutral

AstraZeneca has priced a €2.55 billion bond issuance split into four fixed-rate tranches maturing between 2030 and 2038. The bonds, issued by its US subsidiary and guaranteed by the parent company, carry coupons ranging from 3.402% to 4.169%, reflecting longer maturities demanding higher returns. This move aligns with AstraZeneca's long-term funding strategy to support its expanding pipeline and manufacturing investments, particularly in the US. The bonds will be listed on the London Stock Exchange and managed by Barclays, Goldman Sachs International, and Morgan Stanley.

More News (AZN)

AstraZeneca maintains growth outlook despite cancer drug trial setback

AstraZeneca faced a setback with the discontinuation of its volrustomig trial for non-small cell lung cancer, but strong clinical results for drugs like Tagrisso and Enhertu support its growth prospects. Investment firm CICC gave AstraZeneca an "Outp...

Market News

Bullish

3 days ago